Filing Details
- Accession Number:
- 0001144204-18-007642
- Form Type:
- 13G Filing
- Publication Date:
- 2018-02-13 12:19:03
- Filed By:
- Foresite Capital Fund Ii, L.p.
- Company:
- Alder Biopharmaceuticals Inc (NASDAQ:ALDR)
- Filing Date:
- 2018-02-13
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Foresite Capital Fund II | 1,067,832 | 1,067,832 | 1,067,832 | 1.6% | ||
Foresite Capital Management II | 1,067,832 | 1,067,832 | 1,067,832 | 1.6% | ||
Foresite Capital Fund III | 2,847,130 | 2,847,130 | 2,847,130 | 4.2% | ||
Foresite Capital Management III | 2,847,130 | 2,847,130 | 2,847,130 | 4.2% | ||
Foresite Capital Fund IV | 232,909 | 232,909 | 232,909 | 0.3% | ||
Foresite Capital Management IV | 232,909 | 232,909 | 232,909 | 0.3% | ||
James Tananbaum ( Tananbaum ) | 4,147,871 | 4,147,871 | 4,147,871 | 6.1% |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b)
(Amendment No. 2)*
Alder BioPharmaceuticals, Inc. |
(Name of Issuer) |
Common Stock |
(Title of Class of Securities) |
014339105 |
(CUSIP Number) |
December 31, 2017 |
(Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ | Rule 13d-1(b) |
x | Rule 13d-1(c) |
¨ | Rule 13d-1(d) |
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
(Continued on following pages)
Page 1 of 13
Exhibit Index on Page 12
CUSIP # 014339105 | Page 2 of 13 |
1 | NAME OF REPORTING PERSONS Foresite Capital Fund II, L.P. (“FCF II”) | |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
| (a) ¨ (b) x |
3 | SEC USE ONLY | |
4 | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
| 5 | SOLE VOTING POWER
|
6 | SHARED VOTING POWER See response to row 5. | |
7 | SOLE DISPOSITIVE POWER | |
8 | SHARED DISPOSITIVE POWER See response to row 7. |
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | 1,067,832 |
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | ¨ |
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
| 1.6% |
12 | TYPE OF REPORTING PERSON | PN |
CUSIP # 014339105 | Page 3 of 13 |
1 | NAME OF REPORTING PERSONS Foresite Capital Management II, LLC (“FCM II”) | |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
| (a) ¨ (b) x |
3 | SEC USE ONLY | |
4 | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
| 5 | SOLE VOTING POWER
|
6 | SHARED VOTING POWER See response to row 5. | |
7 | SOLE DISPOSITIVE POWER 1,067,832 shares (including 24,000 shares represented by call options exercisable within sixty days of December 31, 2017), all of which are directly owned by FCF II. FCM II, the general partner of FCF II, may be deemed to have sole power to dispose of these shares, and Tananbaum, the managing member of FCM II, may be deemed to have sole power to dispose of these shares. | |
8 | SHARED DISPOSITIVE POWER See response to row 7. |
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | 1,067,832 |
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | ¨ |
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
| 1.6% |
12 | TYPE OF REPORTING PERSON | OO |
CUSIP # 014339105 | Page 4 of 13 |
1 | NAME OF REPORTING PERSONS Foresite Capital Fund III, L.P. (“FCF III”) | |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
| (a) ¨ (b) x |
3 | SEC USE ONLY | |
4 | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
| 5 | SOLE VOTING POWER
|
6 | SHARED VOTING POWER See response to row 5. | |
7 | SOLE DISPOSITIVE POWER 2,847,130 shares, except that FCM III, the general partner of FCF III, may be deemed to have sole power to dispose of these shares, and Tananbaum, the managing member of FCM III, may be deemed to have sole power to dispose of these shares. | |
8 | SHARED DISPOSITIVE POWER See response to row 7. |
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | 2,847,130 |
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | ¨ |
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
| 4.2% |
12 | TYPE OF REPORTING PERSON | PN |
CUSIP # 014339105 | Page 5 of 13 |
1 | NAME OF REPORTING PERSONS Foresite Capital Management III, LLC (“FCM III”) | |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
| (a) ¨ (b) x |
3 | SEC USE ONLY | |
4 | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
| 5 | SOLE VOTING POWER
|
6 | SHARED VOTING POWER See response to row 5. | |
7 | SOLE DISPOSITIVE POWER 2,847,130 shares, all of which are directly owned by FCF III. FCM III, the general partner of FCF III, may be deemed to have sole power to dispose of these shares, and Tananbaum, the managing member of FCM III, may be deemed to have sole power to dispose of these shares. | |
8 | SHARED DISPOSITIVE POWER See response to row 7. |
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | 2,847,130 |
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | ¨ |
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
| 4.2% |
12 | TYPE OF REPORTING PERSON | OO |
CUSIP # 014339105 | Page 6 of 13 |
1 | NAME OF REPORTING PERSONS Foresite Capital Fund IV, L.P. (“FCF IV”) | |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
| (a) ¨ (b) x |
3 | SEC USE ONLY | |
4 | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
| 5 | SOLE VOTING POWER
|
6 | SHARED VOTING POWER See response to row 5. | |
7 | SOLE DISPOSITIVE POWER 232,909 shares, except that FCM IV, the general partner of FCF IV, may be deemed to have sole power to dispose of these shares, and Tananbaum, the managing member of FCM IV, may be deemed to have sole power to dispose of these shares. | |
8 | SHARED DISPOSITIVE POWER See response to row 7. |
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | 232,909 |
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | ¨ |
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
| 0.3% |
12 | TYPE OF REPORTING PERSON | PN |
CUSIP # 014339105 | Page 7 of 13 |
1 | NAME OF REPORTING PERSONS Foresite Capital Management IV, LLC (“FCM IV”) | |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
| (a) ¨ (b) x |
3 | SEC USE ONLY | |
4 | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
| 5 | SOLE VOTING POWER
|
6 | SHARED VOTING POWER See response to row 5. | |
7 | SOLE DISPOSITIVE POWER 232,909 shares, all of which are directly owned by FCF IV. FCM IV, the general partner of FCF IV, may be deemed to have sole power to dispose of these shares, and Tananbaum, the managing member of FCM IV, may be deemed to have sole power to dispose of these shares. | |
8 | SHARED DISPOSITIVE POWER See response to row 7. |
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | 232,909 |
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | ¨ |
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
| 0.3% |
12 | TYPE OF REPORTING PERSON | OO |
CUSIP # 014339105 | Page 8 of 13 |
1 | NAME OF REPORTING PERSONS James Tananbaum (“Tananbaum”) | |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
| (a) ¨ (b) x |
3 | SEC USE ONLY | |
4 | CITIZENSHIP OR PLACE OF ORGANIZATION United States |
| 5 | SOLE VOTING POWER
|
6 | SHARED VOTING POWER See response to row 5. | |
7 | SOLE DISPOSITIVE POWER 4,147,871 shares, of which 1,067,832 shares (including 24,000 shares represented by call options exercisable within sixty days of December 31, 2017) are directly owned by FCF II, 2,847,130 shares are directly owned by FCF III, and 232,909 shares are directly owned by FCF IV. Tananbaum is the managing member of each of FCM II, which is the general partner of FCF II, FCM III, which is the general partner of FCF III, and FCM IV, which is the general partner of FCF IV. Tananbaum may be deemed to have sole power to dispose of these shares. | |
8 | SHARED DISPOSITIVE POWER See response to row 7. |
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | 4,147,871 |
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | ¨ |
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
| 6.1% |
12 | TYPE OF REPORTING PERSON | IN |
CUSIP # 014339105 | Page 9 of 13 |
ITEM 1(A). | NAME OF ISSUER |
Alder BioPharmaceuticals, Inc. (the “Issuer”)
ITEM 1(B). | ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES |
11804 North Creek Parkway South
Bothell, WA 98011
ITEM 2(A). | NAME OF PERSONS FILING |
This Schedule is filed by Foresite Capital Fund II, L.P., a Delaware limited partnership, Foresite Capital Management II, LLC, a Delaware limited liability company, Foresite Capital Fund III, L.P., a Delaware limited partnership, Foresite Capital Management III, LLC, a Delaware limited liability company, Foresite Capital Fund IV, L.P., a Delaware limited partnership, Foresite Capital Management IV, LLC, a Delaware limited liability company and James Tananbaum. The foregoing entities and individuals are collectively referred to as the “Reporting Persons.”
ITEM 2(B). | ADDRESS OF PRINCIPAL OFFICE |
The address for each of the Reporting Persons is:
c/o Foresite Capital Management
600 Montgomery Street, Suite 4500
San Francisco, CA 94111
ITEM 2(C). | CITIZENSHIP
See Row 4 of cover page for each Reporting Person. |
ITEM 2(D). | TITLE OF CLASS OF SECURITIES |
Common Stock
ITEM 2(E) | CUSIP NUMBER |
014339105
ITEM 3. | If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: |
Not applicable.
ITEM 4. | OWNERSHIP |
The following information with respect to the ownership of the common stock of the Issuer by the persons filing this Statement is provided as of December 31, 2017:
(a) | Amount beneficially owned: |
See Row 9 of cover page for each Reporting Person.
(b) | Percent of Class:
See Row 11 of cover page for each Reporting Person. |
CUSIP # 014339105 | Page 10 of 13 |
(c) | Number of shares as to which such person has: |
(i) | Sole power to vote or to direct the vote: |
See Row 5 of cover page for each Reporting Person.
(ii) | Shared power to vote or to direct the vote: |
See Row 6 of cover page for each Reporting Person.
(iii) | Sole power to dispose or to direct the disposition of: |
See Row 7 of cover page for each Reporting Person.
(iv) | Shared power to dispose or to direct the disposition of: |
See Row 8 of cover page for each Reporting Person.
ITEM 5. | OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS |
Not applicable
ITEM 6. | OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. |
Under certain circumstances set forth in the limited partnership agreements of FCF II, FCF III and FCF IV and the limited liability company agreements of FCM II, FCM III and FCM IV the partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from the sale of, shares of the Issuer directly or indirectly owned by each such entity of which they are a partner or member.
ITEM 7. | IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY |
Not applicable.
ITEM 8. | IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. |
Not applicable
ITEM 9. | NOTICE OF DISSOLUTION OF GROUP. |
Not applicable
ITEM 10. | CERTIFICATION. |
By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
CUSIP # 014339105 | Page 11 of 13 |
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 13, 2018
FORESITE CAPITAL FUND II, L.P. | ||
By: | FORESITE CAPITAL MANAGEMENT II, LLC | |
Its: | General Partner | |
By: | /s/ James Tananbaum | |
Name: | James Tananbaum | |
Title: | Managing Member | |
FORESITE CAPITAL MANAGEMENT II, LLC | ||
By: | /s/ James Tananbaum | |
Name: | James Tananbaum | |
Title: | Managing Member | |
FORESITE CAPITAL FUND III, L.P. | ||
By: | FORESITE CAPITAL MANAGEMENT III, LLC | |
Its: | General Partner | |
By: | /s/ James Tananbaum | |
Name: | James Tananbaum | |
Title: | Managing Member | |
FORESITE CAPITAL MANAGEMENT III, LLC | ||
By: | /s/ James Tananbaum | |
Name: | James Tananbaum | |
Title: | Managing Member | |
FORESITE CAPITAL FUND IV, L.P. | ||
By: | FORESITE CAPITAL MANAGEMENT IV, LLC | |
Its: | General Partner | |
By: | /s/ James Tananbaum | |
Name: | James Tananbaum | |
Title: | Managing Member | |
FORESITE CAPITAL MANAGEMENT IV, LLC | ||
By: | /s/ James Tananbaum | |
Name: | James Tananbaum | |
Title: | Managing Member | |
JAMES TANANBAUM | ||
By: | /s/ James Tananbaum | |
Name: | James Tananbaum |
CUSIP # 014339105 | Page 12 of 13 |
EXHIBIT INDEX
Found on Sequentially | ||
Exhibit | Numbered Page | |
Exhibit A: Agreement of Joint Filing | 13 |
CUSIP # 014339105 | Page 13 of 13 |
exhibit A
Agreement of Joint Filing
The Reporting Persons hereby agree that a single Schedule 13G (or any amendment thereto) relating to the common stock of the Issuer shall be filed on behalf of each of the Reporting Persons. Note that a copy of the applicable Agreement of Joint Filing is already on file with the appropriate agencies.